BioPharma Credit PLC declare an interim dividend in respect of the financial period ended 30 September 2023 of $0.0375 per ordinary share, payable on 5 January 2024 to ordinary shareholders on the register as at 8 December 2023. The ex-dividend date will be 7 December 2023. The $0.0375 dividend comprises an ordinary dividend of $0.0175 and a special dividend of $0.0200The Company is currently paying and continues to target a 7 cent annual dividend per ordinary share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.836 USD | -0.24% | -1.18% | -0.48% |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
May. 02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
-0.48% | 1.02B | |
+7.69% | 13.26B | |
+11.85% | 9.55B | |
+2.65% | 5.74B | |
+7.30% | 5.27B | |
-0.71% | 5.11B | |
+26.36% | 4.99B | |
+20.18% | 4.59B | |
+1.45% | 3.98B | |
+5.29% | 3.97B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- BioPharma Credit PLC Declares Interim Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024